Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Iron Deficiencies 1Anemia 1

Interventions

Epoetin Alfa 8ferric carboxymaltose 6epoetin beta 6Meropenem 6Ceftazidime 5Vancomycin 4Darbepoetin alfa 4apixaban 3Enoxaparin 3Ciprofloxacin 3Cefepime 3iron isomaltoside 1000 2ferrous sulfate 2ferrous fumarate 2Teicoplanin 2Radiotherapy 2Levofloxacin 2Filgrastim 2Dalteparin 2Cholecalciferol 2Aspirin 2Amikacin 2sotorasib 1posaconazole 1ferrous succinate 1ferric gluconate 1eltrombopag 1ceftolozane, tazobactam drug combination 1Vitamin B 12 1Vaccination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × ferric gluconate × Classical hematology × Clear all
NCT00224068 2012-03-02

Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy

Watson Pharmaceuticals

Phase 4 Completed
180 enrolled
Classical hematology

Iron Deficiencies, Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡